Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Other Working Capital Changes (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 5 years of Other Working Capital Changes data on record, last reported at -$367928.0 in Q3 2025.

  • For Q3 2025, Other Working Capital Changes fell 134.53% year-over-year to -$367928.0; the TTM value through Sep 2025 reached -$269663.0, down 144.08%, while the annual FY2024 figure was -$38047.0, 25.47% down from the prior year.
  • Other Working Capital Changes reached -$367928.0 in Q3 2025 per COEP's latest filing, down from -$10453.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $118833.0 in Q4 2024 and bottomed at -$367928.0 in Q3 2025.
  • Average Other Working Capital Changes over 5 years is -$30415.9, with a median of -$10453.0 recorded in 2025.
  • The widest YoY moves for Other Working Capital Changes: up 22407.69% in 2023, down 5105.26% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at $33145.0 in 2021, then crashed by 100.63% to -$208.0 in 2022, then surged by 22407.69% to $46400.0 in 2023, then skyrocketed by 156.11% to $118833.0 in 2024, then tumbled by 409.62% to -$367928.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$367928.0 in Q3 2025, -$10453.0 in Q2 2025, and -$10115.0 in Q1 2025.